Saving Ends In...
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025BCEC, Boston, USAKey Sessions
Jessica Federer
Investing in Biotech Breakthroughs: A VC Outlook
Angelini Ventures
Ruchira Glaser
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
Novartis
Lei Meng
Series A Secured, What's Next? Scaling Your Biotech
Bain Capital Life Sciences
Scott DeWire
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
Boehringer Ingelheim
Jason Hafler
Funding Biotech Innovation: The CVC Perspective
Sanofi Ventures
Joe Heanue
Medtech’s Next Big Thing: Where the Big Players Are Placing Their Focus
Triple Ring Technologies
Mike Patten
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
Harbour BioMed
Wayne Jarvis
Mapping the Medtech M&A Landscape: Strategies for Companies in a Changing Market
Coloplast
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
Biotech Leaders Morning Keynote Plenary
8:55am - 9:00am
LSX Welcome Address
9:00am - 9:50am
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
- Ruchira Glaser - Chief Medical Officer & Global Head of Clinical Development, Novartis
- Maha Radhakrishnan - Executive Partner, Sofinnova Investments
- Mary Schaheen - President, Prevail Partners
- Geeta Vemuri - Founder & Managing Partner, Agent Capital
9:50am - 10:30am
Fireside Chat: Opportunities and Challenges Ahead for Biopharma – Looking to 2026
Showing 3 of 3 Streams
Biotech Leaders Capital Markets & Investment
Biotech Leaders Partnerships & Deal Making
Market Opportunities & Commercialisation
11:00am - 11:50am
Investing in Biotech Breakthroughs: A VC Outlook
- Jessica Federer - Board Member, Angelini Ventures
- Jeffrey Quillen - Partner, Foley Hoag LLP
- Hal Paz - Operating Partner, Khosla Ventures
- Soyoung Park - General Partner, 1004 Venture Partners
- Sally Wang Liang - Managing Partner, Xpanse Venture
- Pierre Joffrin - Senior Associate, Syncona
11:50am - 12:40pm
Funding Biotech Innovation: The CVC Perspective
- Jason Hafler - Managing Director, Sanofi Ventures
- Marian Nakada - VP, Venture Investments, JJDC
- Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
- Cookie Yu - Investment Director, Samsung Ventures
11:00am - 11:50am
Partnerships That Pay Off: The Blueprint for Biopharma Success
- Jon Kiburz - VP Transactions, R&D Business Development, GSK
- Clare Fisher - SVP BD and M&A, BeiGene
- Anu Connor - VP, Head of Oncology External Innovation, IPSEN
11:50am - 12:40pm
Licensing Goldmines: Turning Intellectual Property into Biotech Success
- Carla Bauer - Director, Oncology S&E, BD&L, Merck
- Swarna Balasubramanian - Associate Director, S&E, BD&L, AstraZeneca
- Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka Pharmaceuticals
11:00am - 11:50am
From Molecules to Millions: How to Build a Biotech Powerhouse
- Scott Saywell - EVP, Corporate Development, Coherus BioSciences
- Paul Bresge - CEO, Ray Therapeutics
- Joe Goldberg - National Life Sciences Industry Consulting Leader, RSM US LLP
- Milenko Cicmil - CEO & Co-Founder, Tasca Therapeutics
- Rich Yang - CEO, Biolinq
11:50am - 12:40pm
New Approach Methodologies (NAMs): Challenges and Opportunities for Biotech Innovators working to Reduce Animal Testing
- Julie Frearson - SVP Chief Scientific Officer, Charles River Laboratories
Showing 3 of 3 Streams
Biotech Leaders Capital Markets & Investment
Biotech Leaders Partnerships & Deal Making
Market Opportunities & Commercialisation
1:40pm - 2:30pm
Beyond the Pitch: Landing Early-Stage VC Funding
- Mahesh Narayanan - Managing Partner, Neuvation Ventures
- Salar Roshan - Operating Partner, 3E Bioventures Capital
- Giles Hamilton - Operating Partner, New Growth Advisors
- Sonia Gulati - Principal, Global BioAccess Fund
2:30pm - 3:20pm
Series A Secured, What's Next? Scaling Your Biotech
- Lei Meng - Managing Director, Life Sciences, Bain Capital Life Sciences
- Evan Caplan - Principal, OrbiMed
- Jamil Bag - Partner, SV Health Investors
- John Boyce - Managing Director and Co-Founder, TigerGene
1:40pm - 2:30pm
Collaborating for Innovation: The Role of Research Partnerships in Biotech
- Simone Mori - Program Leader - External Research Venture, Moderna
- Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
- Alicia Zhou - CEO, Cancer Research Institute
- Peng Leong - CBO and Therapeutic Area Head, Brain Aging, BioAge
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
2:30pm - 3:20pm
Sealing the Deal: Powering Autoimmune Breakthroughs Through Strategic Investment & Partnerships
- Laura Tadvalkar - Managing Director, RA Capital
- Saifur Rahman - Senior Director Business Development & Licensing, Sanofi
- John Mayfield - SVP, Business Development & Strategy, Flagship Pioneering
- Paul Oppold - VP, Investments & Head of Corporate Development, Roivant Sciences
1:40pm - 2:30pm
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
- Mike Patten - Chief Strategy Officer, Harbour BioMed
- Armin Rump - Associate Director, Global Business Development, Otsuka Pharmaceutical
- Osamu Nakanishi - President, Kissei America Inc.
2:30pm - 3:20pm
Talent for Tomorrow: How to Leverage a Hybrid Workforce for Innovation and Growth
- Eric Fink - Managing Partner & Co-CEO, Slone Partners
- Christine Horton - CEO, Visura Technologies
- Sam Windsor - CEO, Ignota Labs
Showing 1 of 1 Streams
Biotech Leaders Afternoon Keynote Plenary
3:50pm - 4:40pm
Biotech's Next Chapter: Innovating Smarter in a Changing Financial Landscape
- Elizabeth Bailey - Co-Founder & Managing Partner, Foreground Capital
- Kristian Werling - Global Head, Health and Life Sciences Practice Group, McDermott Will & Emery
- Luba Greenwood - Managing Partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
- Devin Rosenthal - Principal & Head of Due Diligence, NovaQuest Capital Management
- Greg Fralish - CBO, GlycoEra
- Bernard Cooney - Senior Partner, Flagship Pioneering
4:40pm - 5:30pm
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
- Scott DeWire - Corporate SVP, Head of Global BD&L, Boehringer Ingelheim
- Nicole Daley - Partner, A&O Shearman
- Konstantina Katcheves - SVP, Business Development, Alliance Management, & Acquisitions, Teva Pharmaceuticals
- Stu Mackey - Global Head of Business Development, Daiichi-Sankyo
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas Pharma
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats